These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 28964435)

  • 1. A New Statistical Method to Determine the Degree of Validity of Health Economic Model Outcomes against Empirical Data.
    Corro Ramos I; van Voorn GAK; Vemer P; Feenstra TL; Al MJ
    Value Health; 2017 Sep; 20(8):1041-1047. PubMed ID: 28964435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decision analytical economic modelling within a Bayesian framework: application to prophylactic antibiotics use for caesarean section.
    Cooper NJ; Sutton AJ; Abrams KR
    Stat Methods Med Res; 2002 Dec; 11(6):491-512. PubMed ID: 12516986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the Economic and Health Outcomes Model of Type 2 Diabetes Mellitus (ECHO-T2DM).
    Willis M; Johansen P; Nilsson A; Asseburg C
    Pharmacoeconomics; 2017 Mar; 35(3):375-396. PubMed ID: 27838913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AdViSHE: A Validation-Assessment Tool of Health-Economic Models for Decision Makers and Model Users.
    Vemer P; Corro Ramos I; van Voorn GA; Al MJ; Feenstra TL
    Pharmacoeconomics; 2016 Apr; 34(4):349-61. PubMed ID: 26660529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance not statistical significance: a simple Bayesian alternative to p values.
    Burton PR; Gurrin LC; Campbell MJ
    J Epidemiol Community Health; 1998 May; 52(5):318-23. PubMed ID: 9764283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force.
    Sullivan SD; Mauskopf JA; Augustovski F; Jaime Caro J; Lee KM; Minchin M; Orlewska E; Penna P; Rodriguez Barrios JM; Shau WY
    Value Health; 2014; 17(1):5-14. PubMed ID: 24438712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
    Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
    Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calibrating models in economic evaluation: a comparison of alternative measures of goodness of fit, parameter search strategies and convergence criteria.
    Karnon J; Vanni T
    Pharmacoeconomics; 2011 Jan; 29(1):51-62. PubMed ID: 21142278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of economic and health outcomes simulation model of type 2 diabetes mellitus (ECHO-T2DM).
    Willis M; Asseburg C; He J
    J Med Econ; 2013 Aug; 16(8):1007-21. PubMed ID: 23718682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling the value for money of changing clinical practice change: a stochastic application in diabetes care.
    Hoomans T; Abrams KR; Ament AJ; Evers SM; Severens JL
    Med Care; 2009 Oct; 47(10):1053-61. PubMed ID: 19648827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Meta-analysis of the Italian studies on short-term effects of air pollution].
    Biggeri A; Bellini P; Terracini B;
    Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of haemodialysis and peritoneal dialysis for patients with end-stage renal disease in Singapore.
    Yang F; Lau T; Luo N
    Nephrology (Carlton); 2016 Aug; 21(8):669-77. PubMed ID: 26566750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unremarked or Unperformed? Systematic Review on Reporting of Validation Efforts of Health Economic Decision Models in Seasonal Influenza and Early Breast Cancer.
    de Boer PT; Frederix GW; Feenstra TL; Vemer P
    Pharmacoeconomics; 2016 Sep; 34(9):833-45. PubMed ID: 27129572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Part 2. Development of Enhanced Statistical Methods for Assessing Health Effects Associated with an Unknown Number of Major Sources of Multiple Air Pollutants.
    Park ES; Symanski E; Han D; Spiegelman C
    Res Rep Health Eff Inst; 2015 Jun; (183 Pt 1-2):51-113. PubMed ID: 26333239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [REIN Report 2011--summary].
    Couchoud C; Lassalle M; Jacquelinet C
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probabilistic sensitivity analysis: be a Bayesian.
    Boshuizen HC; van Baal PH
    Value Health; 2009; 12(8):1210-4. PubMed ID: 19695002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probabilistic sensitivity analysis in health economics.
    Baio G; Dawid AP
    Stat Methods Med Res; 2015 Dec; 24(6):615-34. PubMed ID: 21930515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The GRACE checklist for rating the quality of observational studies of comparative effectiveness: a tale of hope and caution.
    Dreyer NA; Velentgas P; Westrich K; Dubois R
    J Manag Care Spec Pharm; 2014 Mar; 20(3):301-8. PubMed ID: 24564810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Shared decision-making as a new quality indicator in nephrology: a nationwide survey in Germany].
    Scheibler F; Stoffel MP; Barth C; Kuch C; Steffen P; Baldamus CA; Pfaff H
    Med Klin (Munich); 2005 Apr; 100(4):193-9. PubMed ID: 15834528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Empirical Bayes interval estimates that are conditionally equal to unadjusted confidence intervals or to default prior credibility intervals.
    Bickel DR
    Stat Appl Genet Mol Biol; 2012 Feb; 11(3):Article 7. PubMed ID: 22499708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.